1015474-32-4Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=ORSNPAKAFCAAMBH-UHFFFAOYSA-NAvadomide is under investigation in clinical trial NCT02031419 (Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma).
1015474-32-4読み込み中…
DTXSID701359540CHEMBL3989934